Stock Events

Stock Events

Teva- Pharmaceutical Industries 

€35.00
663
+€1.40+4.17% Friday 06:55

Statistics

Day High
35
Day Low
35
52W High
35
52W Low
33
Volume
150
Avg. Volume
-
Mkt Cap
40.82B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Dec 17
€0.07
Sep 17
€0.07
Jun 17
€0.30
Mar 17
€0.32
Dec 16
€0.33
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

3NovExpected
Q2 2026
Next
0.02
0.22
0.42
0.62
Expected EPS
0.6156274764464993
Actual EPS
N/A

Financials

8.12%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
14.97BRevenue
1.22BNet Income

Analyst Ratings

$33.77Average Price Target
The highest estimate is 37.94.
From 8 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TEVA.F. It's not an investment recommendation.
NVIDIA
122
NVDA
Amazon
118
AMZN
Microsoft
116
MSFT
Apple
115
AAPL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap266.8B
Novartis, through its Sandoz division, is a leading competitor in the generic pharmaceuticals market, directly challenging Teva's product lineup.
Pfizer
PFE
Mkt Cap157.65B
Pfizer, with its Upjohn division now merged into Viatris, competes in both the generic and branded pharmaceutical markets, overlapping with Teva's business areas.
Abbvie
ABBV
Mkt Cap466.45B
AbbVie competes with Teva in the specialty pharmaceutical sector, particularly in areas like biosimilars and branded pharmaceuticals.
Johnson & Johnson
JNJ
Mkt Cap650.65B
Johnson & Johnson, through its Janssen Pharmaceuticals division, competes in the branded pharmaceutical market, particularly in areas where Teva also operates.
Merck
MRK
Mkt Cap362.35B
Merck competes with Teva in the development and marketing of branded pharmaceuticals, especially in therapeutic areas where Teva is active.
Gilead Sciences
GILD
Mkt Cap186.13B
Gilead Sciences competes with Teva in the specialty pharmaceuticals market, particularly in the antiviral sector where Teva also has a presence.
AMGEN
AMGN
Mkt Cap208.49B
Amgen competes with Teva in the biopharmaceutical sector, particularly in the development of biosimilars, a growing area of Teva's business.
Sanofi
SNY
Mkt Cap101.79B
Sanofi competes with Teva in both the branded and generic pharmaceutical markets, with a broad product portfolio that overlaps with Teva's.
Astrazeneca
AZN
Mkt Cap257.57B
AstraZeneca competes with Teva in the branded pharmaceutical sector, particularly in areas like respiratory and cardiovascular diseases where Teva is also active.

About

Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Show more...
CEO
Richard D. Francis
Employees
32842
Country
Israel
ISIN
IL0006290147
WKN
000906517

Listings

XNYS
US
TEVA
SA
BR
T1EV34.SA
TA
IL
TEVA.TA
F
DE
TEVA.F

0 Comments

Share your thoughts

FAQ

What is Teva- Pharmaceutical Industries stock price today?▼
The current price of TEVA.F is €35.00 EUR — it has increased by +4.17% in the past 24 hours. Watch Teva- Pharmaceutical Industries stock price performance more closely on the chart.
What is Teva- Pharmaceutical Industries stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Frankfurt Exchange exchange Teva- Pharmaceutical Industries stocks are traded under the ticker TEVA.F.
What is Teva- Pharmaceutical Industries market cap?▼
Today Teva- Pharmaceutical Industries has the market capitalization of 40.82B
When is the next Teva- Pharmaceutical Industries earnings date?▼
Teva- Pharmaceutical Industries is going to release the next earnings report on November 03, 2026.
What were Teva- Pharmaceutical Industries earnings last quarter?▼
TEVA.F earnings for the last quarter are 0.02 EUR per share, whereas the estimation was 0.05 EUR resulting in a -60.67% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Teva- Pharmaceutical Industries revenue for the last year?▼
Teva- Pharmaceutical Industries revenue for the last year amounts to 14.97B EUR.
What is Teva- Pharmaceutical Industries net income for the last year?▼
TEVA.F net income for the last year is 1.22B EUR.
Does Teva- Pharmaceutical Industries pay dividends?▼
Yes, TEVA.F dividends are paid quarterly. The last dividend per share was 0.07 . As of today, Dividend Yield (FWD)% is 0%.
How many employees does Teva- Pharmaceutical Industries have?▼
As of September 26, 2026, the company has 32,842 employees.
In which sector is Teva- Pharmaceutical Industries located?▼
Teva- Pharmaceutical Industries operates in the Health & Wellness sector.
When did Teva- Pharmaceutical Industries complete a stock split?▼
The last stock split for Teva- Pharmaceutical Industries was on December 06, 2002 with a ratio of 2:1.
Where is Teva- Pharmaceutical Industries headquartered?▼
Teva- Pharmaceutical Industries is headquartered in TEL AVIV, Israel.